Drugs like Wegovy and other GLP-1 medications are reported to have benefits that extend beyond weight loss. These benefits may include targeting arthritis inflammation and improving metabolic health. The potential of these drugs has sparked discussions about their accessibility and affordability, as well as their potential to reduce future health costs.